falsefalse

Marcia Brose, MD, PhD - Episode 1

Approval of Lenvatinib: More Options

Now Viewing
EP. 1: Approval of Lenvatinib: More Options
EP. 2: Who Are the Best Candidates for TKIs?
EP. 3: Interpreting Whole Body Scans
EP. 4: Genetic Testing: What Role Do Mutations Play?
EP. 5: Treatments After Progression in DTC
EP. 6: When to Refer a Patient to a Medical Oncologist
EP. 7: Monitoring During Active Surveillance and Treatment
EP. 8: Key Findings From DECISION and SELECT Trials
EP. 9: Current and Future Targets in Thyroid Cancer
EP. 10: More Personalized Therapy Needed to Improve Survival
EP. 11: Medullary Thyroid Cancer: What is Available?

Related Content:

Marcia Brose, MD, PhDHead & Neck Cancers
The OncFive: Top Oncology Updates for the Week of 6/8
Dr Adkins on the FDA Approval of Pembrolizumab for Neoadjuvant/Adjuvant Treatment in Resectable, Locally Advanced HNSCC
FDA Approves Perioperative Pembrolizumab for Resectable, Locally Advanced HNSCC
x